Advancing the Diagnosis of Non‐Hodgkin Lymphoma Through Next‐Generation Sequencing in Developing Countries: An Evaluation of Progress—A Narrative Review

Background and Aims: Non-Hodgkin lymphoma (NHL) is the most prevalent hematological malignancy worldwide and accounts for approximately 3% of all cancer cases and fatalities. Next-generation sequencing (NGS) has advanced molecular diagnosis and targeted treatment in developed countries. However, developing countries face barriers like limited infrastructure, funding, and expertise, hindering wide NGS adoption. This narrative review evaluates the progress, challenges, and feasibility of using NGS for NHL diagnosis in developing countries. Methods: A comprehensive narrative literature review was conducted. We searched the PubMed, Scopus, and Google Scholar databases for relevant English-language articles published between January 2008 and December 2025. The focus was on synthesizing evidence from studies applying NGS for NHL diagnosis, with particular emphasis on data from developing countries and comparisons with advancements in developed regions. Results: NGS has improved NHL subclassification accuracy and identified clinically relevant mutations, enabling personalized therapies. Studies from China, India, and South Africa demonstrate successful implementation of panel-based NGS strategies. Despite this, challenges persist, including high costs, lack of standardized protocols, infrastructural deficits, and workforce shortages, limiting broader utilization in resource-limited settings. Collaborative efforts and investments have begun to address these issues in some developing countries. Conclusion: NGS promises significant benefits in NHL diagnosis and management in developing countries. Overcoming financial, technical, and training barriers through targeted policies, funding, and international cooperation is crucial to harnessing its full potential. With ongoing advancements, NGS is poised to become a crucial tool for diagnosis and guiding therapy worldwide, including in resource-limited settings.

Authors

Institutions

Publication Details

Journal
Health Science Reports
Published
2026-04-01
DOI
https://doi.org/10.1002/hsr2.71873
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advancing the Diagnosis of Non‐Hodgkin Lymphoma Through Next‐Generation Sequencing in Developing Countries: An Evaluation of Progress—A Narrative Review

Mohammad Panji, Hassan Nourmohammadi, Mohammadreza Saeidnia, Maryam Karimian et al.
Health Science Reports
Cancer Genomics and Diagnostics
article

Advancing the Diagnosis of Non‐Hodgkin Lymphoma Through Next‐Generation Sequencing in Developing Countries: An Evaluation of Progress—A Narrative Review

Mohammad Panji, Hassan Nourmohammadi, Mohammadreza Saeidnia, Maryam Karimian, Elahe Motevaseli, Mashallah Babashahi, Safa Radmehr, Mohamad Moradi, Mehdi Shokri
article en

Abstract

Background and Aims: Non-Hodgkin lymphoma (NHL) is the most prevalent hematological malignancy worldwide and accounts for approximately 3% of all cancer cases and fatalities. Next-generation sequencing (NGS) has advanced molecular diagnosis and targeted treatment in developed countries. However, developing countries face barriers like limited infrastructure, funding, and expertise, hindering wide NGS adoption. This narrative review evaluates the progress, challenges, and feasibility of using NGS for NHL diagnosis in developing countries. Methods: A comprehensive narrative literature review was conducted. We searched the PubMed, Scopus, and Google Scholar databases for relevant English-language articles published between January 2008 and December 2025. The focus was on synthesizing evidence from studies applying NGS for NHL diagnosis, with particular emphasis on data from developing countries and comparisons with advancements in developed regions. Results: NGS has improved NHL subclassification accuracy and identified clinically relevant mutations, enabling personalized therapies. Studies from China, India, and South Africa demonstrate successful implementation of panel-based NGS strategies. Despite this, challenges persist, including high costs, lack of standardized protocols, infrastructural deficits, and workforce shortages, limiting broader utilization in resource-limited settings. Collaborative efforts and investments have begun to address these issues in some developing countries. Conclusion: NGS promises significant benefits in NHL diagnosis and management in developing countries. Overcoming financial, technical, and training barriers through targeted policies, funding, and international cooperation is crucial to harnessing its full potential. With ongoing advancements, NGS is poised to become a crucial tool for diagnosis and guiding therapy worldwide, including in resource-limited settings.

Health Science ReportsVol. 9(4)
Ahvaz Jundishapur University of Medical Sciences (IR), Brigham and Women's Hospital (US), Shiraz University of Medical Sciences (IR), Imam Khomeini Hospital (IR), Ilam University (IR), Tehran University of Medical Sciences (IR)
Openalex Percentile: Top 16%
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.